These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 35448889)
41. Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins. Ciceri P; Cozzolino M Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073439 [TBL] [Abstract][Full Text] [Related]
42. Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease. El Chamieh C; Larabi IA; Laville SM; Jacquelinet C; Combe C; Fouque D; Laville M; Frimat L; Pecoits-Filho R; Lange C; Stengel B; Alencar De Pinho N; Alvarez JC; Massy ZA; Liabeuf S; Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104214 [TBL] [Abstract][Full Text] [Related]
43. Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins. Chao CT; Lin SH Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371477 [TBL] [Abstract][Full Text] [Related]
44. Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD. Pieniazek A; Bernasinska-Slomczewska J; Gwozdzinski L Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201270 [TBL] [Abstract][Full Text] [Related]
45. What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis. Vanholder R; Nigam SK; Burtey S; Glorieux G Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324718 [TBL] [Abstract][Full Text] [Related]
46. Prevalence of atheromatous and non-atheromatous cardiovascular disease by age in chronic kidney disease. Villain C; Metzger M; Combe C; Fouque D; Frimat L; Jacquelinet C; Laville M; Briançon S; Klein J; Schanstra JP; Robinson BM; Mansencal N; Stengel B; Massy ZA Nephrol Dial Transplant; 2020 May; 35(5):827-836. PubMed ID: 30169874 [TBL] [Abstract][Full Text] [Related]
47. Critical Appraisal of Limitations in the Current Definition/Classification of Uremic Toxins. Husain-Syed F; Vanholder R; Rosner MH; Kawanishi H; Sirich TL; Ronco C Blood Purif; 2023; 52(3):221-232. PubMed ID: 36513030 [TBL] [Abstract][Full Text] [Related]
49. Uremic toxins are conditional danger- or homeostasis-associated molecular patterns. Sun Y; Johnson C; Zhou J; Wang L; Li YF; Lu Y; Nanayakkara G; Fu H; Shao Y; Sanchez C; Yang WY; Wang X; Choi ET; Li R; Wang H; Yang XF Front Biosci (Landmark Ed); 2018 Jan; 23(2):348-387. PubMed ID: 28930551 [TBL] [Abstract][Full Text] [Related]
50. Dietary fibre intake is low in paediatric chronic kidney disease patients but its impact on levels of gut-derived uraemic toxins remains uncertain. El Amouri A; Snauwaert E; Foulon A; Vande Moortel C; Van Dyck M; Van Hoeck K; Godefroid N; Glorieux G; Van Biesen W; Vande Walle J; Raes A; Eloot S Pediatr Nephrol; 2021 Jun; 36(6):1589-1595. PubMed ID: 33387017 [TBL] [Abstract][Full Text] [Related]
51. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association. Zoccali C; Mallamaci F; Adamczak M; de Oliveira RB; Massy ZA; Sarafidis P; Agarwal R; Mark PB; Kotanko P; Ferro CJ; Wanner C; Burnier M; Vanholder R; Wiecek A Cardiovasc Res; 2023 Sep; 119(11):2017-2032. PubMed ID: 37249051 [TBL] [Abstract][Full Text] [Related]
52. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins. Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D Nephron; 2017; 137(1):1-7. PubMed ID: 28490014 [TBL] [Abstract][Full Text] [Related]
53. Is there an association between the plasma levels of uremic toxins from gut microbiota and anemia in patients on hemodialysis? Capo-Chichi JCC; Borges NA; de Vargas Reis DCM; Nakao LS; Mafra D Int Urol Nephrol; 2022 Jun; 54(6):1271-1277. PubMed ID: 34561817 [TBL] [Abstract][Full Text] [Related]
54. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112 [TBL] [Abstract][Full Text] [Related]